-
- Posts: 14
- Joined: Sun Jan 25, 2009 4:39 am
Issue: Higher recoveries of up to 110% observed from dissolution run for a drug formulation
Compound: 5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
Column: zorbax eclipse c18 50x4.6, 1.8u
Mobilephase: pH 3, potassium phosphate monobasic 80% with 20% acetonitrile
Column at 45c and wavelength at 220nm, flow 1ml
Sample concn 2ppm in water, injection volume 75 ul
Thanks
